With chilaquiles as their daily fuel in Garza García, Mexico, DSIC 2013 Finalist Team Semka Biomedical Technologies is developing a device capable of performing non-invasive tumor biopsies through blood extraction, specifically targeting metastatic cells that give rise to new tumors in the body and increase chances of death. They will be pitching their innovation at our Final Awards Show here in Austin, TX on Tuesday, May 14, along with four other finalist teams from across the world.
According to the American Cancer Society, 7.6 million people worldwide die each year from cancer. Team Semka Biomedical Technologies advocates that monitoring and screening tools are vital for planning anti-cancer therapies for patients.
“We are a group of researchers and entrepreneurs, and our goal is to develop solutions that help solve the great problems of humanity through the use and application of science and technology in an ethical, ecological and responsible way. We are commited to make a difference in the fight against cancer and to help save thousands of lives in the future!”
While claiming that pizza is the world’s greatest invention since the wheel, this inspiring team is driven toward their end-goal of taking their technology global to improve the cancer monitoring and treatment process. By developing a complete health solution that helps people, doctors, hospitals, and the government, this team aims to reduce cancer mortality and its social and economic impact on society.
Within one year, they plan to finish a fully functional prototype – and they are driven to have their device ready for clinical trials within three years. At the five-year mark, they hope to equip doctors at Latin America’s largest cancer centers to save thousands of lives annually.
Recognizing the value and beauty in strategic collaboration, this team is motivated to eventually collaborate with the National Council of Science and Technology.
“We are currently manufacturing our prototype in collaboration with FEMSA Biotechnology Center and developing this technology with physicians, graduate students, and undergraduate students from Monterrey Institute of Technology. Our research receives financial aid of FEMSA Foundation and legal advice from Invomex Consulting Company. We are talking with health representatives in government and health centers to create a future alliance with them and test our technology in clinical environments for testing.”